From coding in Kampala school labs to building custom AI systems in Toronto, Declan Trevor Kintu is proving that Ugandan ...

If you’ve been a longtime web user or web developer, then long ago you probably wouldn’t have imagined how complex the modern web would become, nor how capable just HTML and CSS would ...

Hosted by Becky Quick, CNBC will debut an in-depth, one-hour special, “CNBC Cures: Defying Rare Disease,” spotlighting the families dealing with rare diseases and the scientists, advocates, and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The downtown steakhouse closed ...

Claude extension flaw enabled silent prompt injection via XSS and weak allowlist, risking data theft and impersonation until ...

Hosted by Becky Quick, CNBC will debut an in-depth, one-hour special, “CNBC Cures: Defying Rare Disease,” spotlighting the families dealing with rare diseases and the scientists, advocates, and ...

REalloys (NASDAQ: ALOY) and a small number of other North American companies are doing what the rest of the Western world failed to do for three decades: They are breaking China’s "kill switch" on the ...

The Export-Import Bank is providing a $10 billion loan to Project Vault, an initiative to stockpile critical minerals. The project is the administration’s latest effort to reduce reliance on China. By ...

USA Rare Earth (NASDAQ: USAR) recently updated investors on its medium-term plans as it enters a multiyear execution period, backed by U.S. government and private investment. Buying the stock is not a ...

Add Yahoo as a preferred source to see more of our stories on Google. The stamps date back to the 19th century [JC Auctions] A block of rare postage stamps, found hidden in a cupboard, could be worth ...

STILLWATER, Okla., March 09, 2026 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (“USAR” or the “Company”) today announced the appointment of three senior executives: Valerie Ford Jacob as ...

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors ...